Parallax Volatility Advisers, L.P. Biomarin Pharmaceutical Inc Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 18,853 shares of BMRN stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,853

Previous 15,650 20.47%

Holding current value

$1.26 Million

Previous $1.29 Million 2.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $221,071 - $300,569	3,203 Added 20.47%	18,853 $1.33 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $300,846 - $372,753	4,042 Added 34.82%	15,650 $1.29 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $972,866 - $1.15 Million	11,608 New	11,608 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $799,861 - $971,851	-11,190 Reduced 94.88%	604 $50,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $1.41 Million - $1.61 Million	-18,848 Reduced 61.51%	11,794 $912,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $391,896 - $440,060	5,190 Added 20.39%	30,642 $2.56 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1.76 Million - $2.14 Million	23,579 Added 1258.89%	25,452 $1.92 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $48,648 - $60,434	670 Added 55.69%	1,873 $164,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $33,275 - $60,666	463 Added 62.57%	1,203 $92,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $2.01 Million - $3.15 Million	-25,326 Reduced 97.16%	740 $91,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $1.66 Million - $2.25 Million	23,191 Added 806.64%	26,066 $2.2 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $107,973 - $145,101	1,680 Added 140.59%	2,875 $243,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $1.92 Million - $2.43 Million	-28,494 Reduced 95.97%	1,195 $80,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $325,015 - $379,825	4,045 Added 15.77%	29,689 $2.54 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $546,963 - $640,635	6,496 Added 33.93%	25,644 $2.28 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $1.18 Million - $1.56 Million	14,689 Added 329.42%	19,148 $1.63 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $1.54 Million - $1.73 Million	-16,368 Reduced 78.59%	4,459 $432,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $1.58 Million - $2.06 Million	20,827 New	20,827 $1.96 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Biomarin Pharmaceutical Inc Transaction History